|
|||||
|
|
Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacy |
|
| Authors: | A. R. Brooks D. Sim U. Gritzan C. Patel E. Blasko R. I. Feldman L. Tang E. Ho X.‐Y. Zhao H. Apeler J. E. Murphy |
| Affiliation: | 1. Biologics Research, Bayer Healthcare Pharmaceuticals, , San Francisco, CA, USA;2. Biologics Research, Bayer Healthcare Pharmaceuticals, , Cologne, Germany;3. Biologics Research, Bayer Healthcare Pharmaceuticals, , Wuppertal, Germany |
| Abstract: | |
| Keywords: | coagulation factor IX glycosylation hemophilia B injections pharmacokinetics subcutaneous |